Table of Content

1 Market Overview
1.1 Market Definition
1.2 Global Imaging CRO Market Footprint
1.3 Realistic and Optimistic View of Global Imaging CRO Market, $Million, 2020-2031
1.4 Current Imaging CRO Landscape

2 Industry Analysis
2.1 Regulatory Framework in the U.S.
2.1.1 Imaging CRO Workflow
2.2 Regulatory Framework in Europe
2.3 Regulatory Framework in Asia-Pacific Countries
2.3.1 China
2.3.2 Japan

3 Market Dynamics
3.1 Market Dynamics
3.1.1 Drivers
3.1.1.1 Continued Growth in R&D Spending
3.1.1.2 Increase in the Annual Number of Clinical Trials with Medical Imaging
3.1.2 Restraints
3.1.2.1 High Installation Cost of Medical Imaging Systems
3.1.2.2 Supply Chain and Logistical Challenges
3.1.3 Opportunities
3.1.3.1 Increasing Outsourcing Trend Among Pharmaceutical Companies
3.1.3.2 Automation in Imaging CRO Process

4 Competitive Landscape
4.1 Overview
4.2 Synergistic Activities
4.2.1 Mergers and Acquisitions
4.2.2 New Service Launch
4.2.3 Expansion
4.3 Market Share Analysis, By Company
4.4 Growth Share Analysis, By Company

5 Services, $Million, 2020-2031
5.1 Overview
5.1.1 Imaging Acquisition and Protocol Development
5.1.2 Application Design
5.1.3 Image Collection and QC
5.1.4 Digital Image Conversion
5.1.5 Support and Maintenance

6 Modalities, $Million, 2020-2031
6.1 Overview
6.1.1 Computed Tomography (CT) Scan
6.1.2 Magnetic Resonance Imaging (MRI)
6.1.2.1 Diffusion Tensor Imaging (DTI)
6.1.2.2 Functional MRI (fMRI)
6.1.2.3 Resting-State Functional Connectivity MRI (fcMRI)
6.1.2.4 Volumetric MRI (vMRI)
6.1.2.5 Arterial Spin Labeling for Quantitative Perfusion Imaging (ASL)
6.1.3 Positron Emission Tomography (PET)
6.1.3.1 Positron Emission Tomography with 18F Isotope (FDG-PET)
6.1.3.2 Other PET
6.1.4 Other Modalities
6.1.4.1 X-Rays
6.1.4.2 Ultrasound
6.1.4.3 Scanning Laser Ophthalmoscopy (SLO)
6.1.4.4 Optical Coherence Tomography
6.1.4.5 Scanning Laser Polarimetry (SLP)
6.1.4.6 Others

7 Clinical Trial Phase, $Million, 2020-2031
7.1 Overview
7.1.1 Phase I
7.1.2 Phase II
7.1.3 Phase III

8 Applications, $Million, 2020-2031
8.1 Overview
8.1.1 Oncology Imaging CRO
8.1.2 Ophthalmology Imaging CRO
8.1.3 Neurology Imaging CRO
8.1.4 Cardiology Imaging CRO
8.1.5 Other Applications

9 End-User, $Million, 2020-2031
9.1 Overview
9.1.1 Pharmaceutical Companies
9.1.2 Biotechnology Companies
9.1.3 Medical Device Manufacturers
9.1.4 Contract Research Organizations (CRO)
9.1.5 Academic and Government Research Institutes
9.1.6 Other End Users

10 Regions, $Million, 2020-2031
10.1 Overview
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest-of-Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 Australia
10.4.5 Rest-of-Asia-Pacific
10.5 Rest-of-the-World

11 Company Profile
11.1 Overview
11.2 Worldcare Clinical, LLC
11.2.1 Company Overview
11.2.2 Role of Worldcare Clinical, LLC in the Global Imaging CRO Market
11.2.3 SWOT Analysis
11.3 LabCorp Drug Development (Laboratory Corporation of America Holdings)
11.3.1 Company Overview
11.3.2 Role of LabCorp Drug Development in the Global Imaging CRO Market
11.3.3 Financials
11.3.4 SWOT Analysis
11.4 IXICO PLC
11.4.1 Company Overview
11.4.2 Financials
11.4.3 SWOT Analysis
11.5 ICON plc
11.5.1 Company Overview
11.5.2 Role of ICON plc in the Global Imaging CRO Market
11.5.3 Financials
11.5.4 SWOT Analysis
11.6 The Micron Group
11.6.1 Company Overview
11.6.2 SWOT Analysis
11.7 Medpace Holdings, Inc.
11.7.1 Company Overview
11.7.2 Financials
11.7.3 SWOT Analysis
11.8 Radiant Sage LLC
11.8.1 Company Overview
11.8.2 SWOT Analysis
11.9 Biomedical Systems Corporation (ERT)
11.9.1 Company Overview
11.9.2 SWOT Analysis
11.1 Bioclinica
11.10.1 Company Overview
11.10.2 SWOT Analysis
11.11 Imaging Endpoints LLC
11.11.1 Company Overview
11.11.2 Role of Imaging Endpoints LLC in the Global Imaging CRO Market
11.11.3 SWOT Analysis
11.12 Parexel International Corporation
11.12.1 Company Overview
11.12.2 Role of Parexel International Corporation in the Global Imaging CRO Market
11.12.3 SWOT Analysis
11.13 Wuxi AppTec
11.13.1 Company Overview
11.13.2 Role of Wuxi AppTec in the Global Imaging CRO Market
11.13.3 Financials
11.13.4 Key Insights About Financial Health of the Company
11.13.5 SWOT Analysis
11.14 Syneos Health, Inc.
11.14.1 Company Overview
11.14.2 Role of Syneos Health, Inc. in the Global Imaging CRO Market
11.14.3 Financials
11.14.4 SWOT Analysis
List of Figures
Figure 1: Global Imaging CRO Market, Realistic and Optimistic Scenario, $Million, 2020-2031
Figure 2: Global Imaging CRO Market Dynamics
Figure 3: Share of Key Market Strategies and Developments, July 2017-July 2021
Figure 4: Growth Share Matrix for Global Imaging CRO Market (by Company), 2019- 2020
Figure 5: Global Imaging CRO Market Research Methodology
Figure 6: Primary Research Methodology
Figure 7: Global Imaging CRO Market, $Million, 2020-2031
Figure 8: Realistic and Optimistic View of Global Imaging CRO Market, $Million, 2020-2031
Figure 9: Overview of CRO and Contract Development and Manufacturing Organization (CDMO) Drug Development Services
Figure 10: Global Imaging CRO Market Dynamics
Figure 11: Share of Key Market Strategies and Developments, July 2017-July 2021
Figure 12: Share of Synergistic Activities (by Company), July 2017- July 2021
Figure 13: Share of Mergers and Acquisitions (by Company), July 2017-July 2021
Figure 14: Market Share Analysis for Global Imaging CRO Market, 2019 and 2020
Figure 15: Growth Share Matrix for Global Imaging CRO Market (by Company), 2019 and 2020
Figure 16: Global Imaging CRO Market (by Service)
Figure 17: Share of Global Imaging CRO Market (by Service), 2020 and 2031
Figure 18: Imaging Acquisition and Protocol Development Market Size and Forecast, $Million, 2020-2031
Figure 19: Application Design Market Size and Forecast, $Million, 2020-2031
Figure 20: Image Collection and QC Market Size and Forecast, $Million, 2020-2031
Figure 21: Digital Image Conversion Market Size and Forecast, $Million, 2020-2031
Figure 22: Support and Maintenance Market Size and Forecast, $Million, 2020-2031
Figure 23: Share of Global Imaging CRO Market (by Modality), $Million, 2020 and 2031
Figure 24: Global Imaging CRO Market (by Computed Tomography (CT) Scan), $Million, 2020-2031
Figure 25: Global Imaging CRO Market (by Magnetic Resonance Imaging (MRI)) $Million, 2020-2031
Figure 26: Global Imaging CRO Market (by Diffusion Tensor Imaging (DTI)), $Million, 2020-2031
Figure 27: Global Imaging CRO Market (by Functional MRI (fMRI)), $Million, 2020-2031
Figure 28: Global Imaging CRO Market (by Resting-State Functional Connectivity MRI (fcMRI)), $Million, 2020-2031
Figure 29: Global Imaging CRO Market (by Volumetric MRI (vMRI)), $Million, 2020-2031
Figure 30: Global Imaging CRO Market (by Arterial Spin Labeling (ASL)), $Million, 2020-2031
Figure 31: Global Imaging CRO Market (by Positron Emission Tomography (PET)), $Million, 2020-2031
Figure 32: Global Imaging CRO Market (by Positron Emission Tomography with 18F Isotope (FDG-PET)), $Million, 2020-2031
Figure 33: Global Imaging CRO Market (by Other PET), $Million, 2020-2031
Figure 34: Global Imaging CRO Market (by Positron Emission Tomography (PET)), $Million, 2020-2031
Figure 35: Global Imaging CRO Market (by X-Ray), $Million, 2020-2031
Figure 36: Global Imaging CRO Market (by Ultrasound), $Million, 2020-2031
Figure 37: Global Imaging CRO Market (by Scanning Laser Ophthalmoscopy (SLO)), $Million, 2020-2031
Figure 38: Global Imaging CRO Market (Optical Coherence Tomography), $Million, 2020-2031
Figure 39: Global Imaging CRO Market (by Scanning Laser Polarimetry (SLP)), $Million, 2020-2031
Figure 40: Global Imaging CRO Market (by Others), $Million, 2020-2031
Figure 41: Global Imaging CRO Market (by End User), $Million, 2020 and 2031
Figure 42: Global Imaging CRO Market (by Phase I), $Million, 2020-2031
Figure 43: Global Imaging CRO Market (by Phase II), $Million, 2020-2031
Figure 44: Global Imaging CRO Market (by Phase III), $Million, 2020-2031
Figure 45: Global Imaging CRO Market (by Application)
Figure 46: Share of Global Imaging CRO Market (by Application), $Million, 2020 and 2031
Figure 47: Global Imaging CRO Market, (by Oncology Imaging CRO), $Million, 2020-2031
Figure 48: Global Imaging CRO Market, (by Ophthalmology Imaging CRO), $Million, 2020-2031
Figure 49: Global Imaging CRO Market, (by Neurology Imaging CRO), $Million, 2020-2031
Figure 50: Global Imaging CRO Market, (by Cardiology Imaging CRO), $Million, 2020-2031
Figure 51: Global Imaging CRO Market, (by Other Applications), $Million, 2020-2031
Figure 52: Global Imaging CRO Market (by End User), $Million, 2020 and 2031
Figure 53: Global Imaging CRO Market, (by Pharmaceutical Companies), $Million, 2020-2031
Figure 54: Global Imaging CRO Market, (by Biotechnology Companies), $Million, 2020-2031
Figure 55: Global Imaging CRO Market, (by Medical Device Manufacturers), $Million, 2020-2031
Figure 56: Global Imaging CRO Market, (by Contract Research Organizations (CRO)), $Million, 2020-2031
Figure 57: Global Imaging CRO Market, (by Academic and Government Research Institutes), $Million, 2020-2031
Figure 58: Global Imaging CRO Market, (by Other End Users), $Million, 2020-2031
Figure 59: Global Imaging CRO Market (by Region), $Million, 2020
Figure 60: Share of North America Imaging CRO Market Revenue (by Country), $Million, 2020-2031
Figure 61: North America: Market Dynamics
Figure 62: U.S. Imaging CRO Market, $Million, 2020-2031
Figure 63: Canada Imaging CRO Market, $Million, 2020-2031
Figure 64: Share of Europe Imaging CRO Market (by Country), $Million, 2020-2031
Figure 65: Europe: Market Dynamics
Figure 66: Germany Imaging CRO Market Revenue, $Million, 2020-2031
Figure 67: U.K. Imaging CRO Market Revenue, $Million, 2020-2031
Figure 68: France Imaging CRO Market Revenue, $Million, 2020-2031
Figure 69: Italy Imaging CRO Market Revenue, $Million, 2020-2031
Figure 70: Spain Imaging CRO Market Revenue, $Million, 2020-2031
Figure 71: Rest-of-Europe Imaging CRO Market Revenue, $Million, 2020-2031
Figure 72: Asia-Pacific: Market Dynamics
Figure 73: Asia-Pacific Imaging CRO Market Revenue (by Country), $Million, 2020-2031,
Figure 74: China Imaging CRO Market Revenue, $Million, 2020-2031
Figure 75: India Imaging CRO Market Revenue, $Million, 2020-2031
Figure 76: Japan Imaging CRO Market Revenue, $Million, 2020-2031
Figure 77: Australia Imaging CRO Market Revenue, $Million, 2020-2031
Figure 78: Rest-of-Asia-Pacific Imaging CRO Market Revenue, $Million, 2020-2031
Figure 79: Rest-of-the-World Imaging CRO Market Revenue, $Million, 2020-2031
Figure 80: Total Number of Companies Profiled
Figure 81: Worldcare Clinical, LLC: Overall Service Portfolio
Figure 82: Worldcare Clinical: SWOT Analysis
Figure 83: LabCorp Drug Development: Overall Service Portfolio
Figure 84: LabCorp Drug Development: Overall Financials, 2018-2020
Figure 85: LabCorp Drug Development: Net Revenue (by Business Segment), 2018-2020
Figure 86: LabCorp Drug Development: Net Revenue (by Region), 2018-2020
Figure 87: LabCorp Drug Development: SWOT Analysis
Figure 88: IXICO PLC: Overall Service Portfolio
Figure 89: IXICO PLC: Overall Financials, 2018-2020
Figure 90: IXICO PLC: Net Revenue (by Region), 2018-2020
Figure 91: IXICO PLC: SWOT Analysis
Figure 92: ICON plc: Overall Service Portfolio
Figure 93: ICON plc: Overall Financials, 2018-2020
Figure 94: ICON plc: Revenue (by Region), 2018-2020
Figure 95: ICON plc: SWOT Analysis
Figure 96: The Micron Group.: Overall Service Portfolio
Figure 97: The Micron Group: SWOT Analysis
Figure 98: Medpace Holdings, Inc.: Overall Service Portfolio
Figure 99: Medpace Holdings, Inc.: Overall Financials, 2018-2020
Figure 100: Medpace Holdings, Inc.: Net Revenue (by Therapeutic Area), 2018-2020
Figure 101: Medpace Holdings, Inc.: SWOT Analysis
Figure 102: Radiant Sage LLC: Overall Service Portfolio
Figure 103: Radiant Sage LLC: SWOT Analysis
Figure 104: Biomedical Systems Corporation (ERT): Overall Service Portfolio
Figure 105: Biomedical Systems Corporation (ERT): SWOT Analysis
Figure 106: Bioclinica: Overall Service Portfolio
Figure 107: Bioclinica: SWOT Analysis
Figure 108: Imaging Endpoints LLC: Overall Service Portfolio
Figure 109: Imaging Endpoints LLC: SWOT Analysis
Figure 110: Parexel International Corporation: Overall Service Portfolio
Figure 111: Parexel International Corporation: SWOT Analysis
Figure 112: Wuxi AppTec: Overall Service Portfolio
Figure 113: Wuxi AppTec: Overall Financials, 2018-2020
Figure 114: Wuxi AppTec: Revenue (by Segment), 2018-2020
Figure 115: Wuxi AppTec: Revenue (by Region), 2018-2020
Figure 116: Wuxi AppTec: R&D Expenditure, 2018-2020
Figure 117: Wuxi AppTec: SWOT Analysis
Figure 118: Syneos Health, Inc.: Overall Service Portfolio
Figure 119: Syneos Health, Inc.: Overall Financials, 2018-2020
Figure 120: Syneos Health, Inc.: Revenue (by Segment), 2018-2020
Figure 121: Syneos Health, Inc.: Revenue (by Region), 2018-2020
Figure 122: Syneos Health, Inc.: SWOT Analysis
List of Tables
Table 1: List of Oncology Related Approvals in 2020
Table 2: Imaging Modalities: Pricing Analysis